While these studies provide some insight into US physicians’ attitudes about initiating insulin in patients with type 2 diabetes, they did not include PCPs, who care for the majority of patients with type 2 diabetes in the USA (8). The gene discussed is INS; the disease is type 2 diabetes mellitus.